EPS growth outshines yearly share price gain, hinting at cautious market sentiment. Despite recent sell-off, long-term investors see 16% annual return over five years, suggesting sell-off may be an opportunity for those seeking long-term growth.
The insider stock selling at Halozyme Therapeutics could raise concerns among shareholders. However, the fact that insiders maintain a considerable amount of shares might suggest some level of alignment between management and smaller shareholders.
Gapping up $Rivian Automotive(RIVN.US)$+6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.) $Celsius Holdings(CELH.US)$+11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
Upgrades •$CubeSmart(CUBE.US)$: Raymond James Upgrades to Strong Buy from Outperform - PT $52 (from $60) •$DTE能源(DTE.US)$: Credit Suisse Upgrades to Outperform from Neutral - PT $140 (from $142) •$爱迪生联合电气(ED.US)$: Guggenheim Upgrades to Neutral from Sell - PT $94 (from $80) •$摩托罗拉解决方案(MSI.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $240 •$墨西哥中北部机场(OMAB.US)$: Morgan Stanley Upgrades to...
13
1
14
举报
RDK79 :
Only noted more downgraded than upgrades, lot of analysts late to the party. And a bunch of new ‘initiated’ by mostly unknown folks, but also a few surprised weren’t previously covered, like DIS.
奥洛兹美医疗股票讨论区
专栏Today's Pre-Market Stock Movers: ABNB, RIVN, AFRM, SPCE and More
$Rivian Automotive(RIVN.US)$ +6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.)
$Celsius Holdings(CELH.US)$ +11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
2022前三季度营收增长40%达到4.8亿,但由于费用的大幅增长,营业利润反而下滑12%,净利润下滑57%到1.44亿。
目前市盈率18.4,市盈率TTM已经达到了34,看起来全年结果也不会太好,目前没有吸引力。
专栏US Top Gap Ups and Downs on 1/11: SONY, TOLL, FERG, NVO and More
Gap Ups
1. $Topbuild(BLD.US)$ - up 2.7%
2. $Atlassian(TEAM.US)$ - up 2.4%
3. $Pool Corp(POOL.US)$ - up 2%
4. $索尼(SONY.US)$ - up 1.9%
5. $托尔兄弟(TOL.US)$ - up 1.8%
6. $查尔斯河实验室(CRL.US)$ - up 1.4%
7. $Gaming & Leisure Properties(GLPI.US)$ - up 1.4%
8. $WPP PLC(WPP.US)$ - up 1.3%...
专栏US Top Gap Ups and Downs on 11/9: META, KR, DIS, RBLX and More
Gap Ups
1. $Axon Enterprise(AXON.US)$ - up 7.79%
2. $韩国电力(KEP.US)$ - up 6.65%
3. $Meta Platforms(META.US)$ - up 3.00%
4. $XP Inc(XP.US)$ - up 2.50%
5. $盖尔道钢铁(GGB.US)$ - up 1.49%
6. $Performance Food(PFGC.US)$ - up 1.47%
7. $克罗格(KR.US)$ - up 1.30%
8. $奥洛兹美医疗(HALO.US)$ - up 0.94...
专栏Today's pre-market stock movers: RBLX, TTD, VLD, WYNN and more
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US)$+17%,$Workiva(WK.US)$ +15.3%,$Arlo Technologies(ARLO.US)$ +12%,$Array Technologies(ARRY.US)$ +10.3%,$Everbridge(EVBG.US)$ +9.7%,$Catalyst Pharmaceuticals(CPRX.US)$ +9.4%,$奥洛兹美医疗(HALO.US)$ +8.7%,$Velo3D(VLD.US)$ +7.6%,$CyberArk(CYBR.US)$ + 6.2%,$美国血液技术(HAE.US)$ +5.8%,$Jackson Financial(JXN.US)$ +5.7% (also increases dividend),$Axon Enterprise(AXON.US)$ +4.8%,...
靜靜的等他向上突破
专栏Top upgrades and downgrades on 5/23
• $CubeSmart(CUBE.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $52 (from $60)
• $DTE能源(DTE.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $140 (from $142)
• $爱迪生联合电气(ED.US)$ : Guggenheim Upgrades to Neutral from Sell - PT $94 (from $80)
• $摩托罗拉解决方案(MSI.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $240
• $墨西哥中北部机场(OMAB.US)$ : Morgan Stanley Upgrades to...
暂无评论